Replies to post #5776 on Avita Medical Ltd (RCEL)

[melody432]

Agree with your synopsis, although I think their institutional holdings are still 30%+ even after the Karst sale. Not bad for a small Aussie biotech. But the people who want to own it outside the US already do. Some don't like the redomicile and have sold or are selling. New buyers in the US will wait until after the event. The overall market outlook isn't helping either. We're sort of in a Mexican standoff at the moment. Still very positive longer term. My 2 cents.

[inversor86]

Any time a reverse split is coming volume drops. Understandably, it increases uncertainty. Avita has held up fairly well though.